Market Place
Sourcing Support
Acorda’s awful bad week gets worse as FDA hands execs another delay on Inbrija
13 Sep 2018 //
ENDPTS
U.S. appeals court invalidates Acorda patents on MS drug
11 Sep 2018 //
CNBC
Acorda shares crater after court dashes hopes for salvaging Ampyra patents
10 Sep 2018 //
ENDPTS
Acorda inks Ampyra generic pacts as Ampyra appeal pends
06 Aug 2018 //
FIERCE PHARMA
After resisting a push to the auction block, Acorda shares shoot up
05 Jan 2018 //
END POINTS
Troubled Acorda hurries to bar the door against a takeover attempt
02 Sep 2017 //
ENDPTS
FDA derails Acorda’s marketing pitch, creating crisis as flagship drug founders
29 Aug 2017 //
ENDPTS
Ampyra® (Dalfampridine): Acorda Therapeutics, Inc. V. Micro Labs
24 May 2017 //
PATENT LITIGATION
Patent challenger Bass wins another review bid, this time on Acorda`s Ampyra
14 Mar 2016 //
FIERCE PHARMA
Catalyst hits an FDA roadblock with its `breakthrough` rare disease drug
18 Feb 2016 //
FIERCE BIOTECH
Pharma`s new patent worry by the numbers: No `IP death squad` here, analyst says
04 Sep 2015 //
FIERCE PHARMA
Drugmakers to Congress: You want patent reforms? Stop pharma challenger Bass
05 May 2015 //
FIERCE PHARMA
Copyright © 2024 LePro PharmaCompass OPC Private Limited, All rights reserved.